Detection of the GD2+/CD56+/CD45-Immunophenotype by Flow Cytometry in Cerebrospinal Fluids from a Patient with Retinoblastoma

被引：8
|
作者：
Shen, Hongqiang [1 ]
Tang, Yongmin [1 ]
Xu, Xiaojun [1 ]
Tang, Hongfeng [1 ]
机构：
[1] Zhejiang Univ, Key Lab Reprod Genet, Div Hematol Oncol, Minist Educ,Childrens Hosp,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
PEDIATRIC HEMATOLOGY AND ONCOLOGY | 2013年 / 30卷 / 01期
关键词：
cerebrospinal fluid; diagnosis; flow cytometry; metastasis; retinoblastoma; METASTATIC RETINOBLASTOMA; CELL;
D O I：
10.3109/08880018.2012.737094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Triple-color flow cytometry with a panel of antibodies comprising GD2, CD56, and CD45 was performed to analyze cerebrospinal fluids (CSF) from a patient with retinoblastoma who was suspicious of meningeal metastasis based on clinical presentation. Our results showed that the cells in CSF demonstrated the immunophenotype positive for GD2 and CD56 but negative for CD45 antigen, which suggested the presence of CSF metastasis of retinoblastoma. At the end of eight cycles of intrathecal chemotherapy, CSF specimen was analyzed with Flow cytometry immunophenotyping (FCI) again and the result showed no detectable malignant cells with the same immunophenotype. Our conclusion is that FCI can be a quick and reliable method for the diagnosis of CSF metastasis of retinoblastoma and the immunophenotype (GD2+, CD56+, and CD45-) can be used to recognize residual retinoblastoma cells in CSF.
引用
收藏
页码：13 / 17
页数：5
相关论文
共 7 条
  • [1] Detection of the CD56+/CD45-immunophenotype by flow cytometry in neuroenclocrine malignancies
    Bryson, GJ
    Lear, D
    Williamson, R
    Wong, RCW
    JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (07) : 535 - 537
  • [2] Detecting CD56+/NB84+/CD45-immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry
    Bozzi, Fabio
    Gambirasio, Felicita
    Luksch, Roberto
    Collini, Paola
    Brando, Bruno
    Fossati-Bellani, Franca
    ANTICANCER RESEARCH, 2006, 26 (5A) : 3281 - 3287
  • [3] Detection of the CD56+/CD45- immunophenotype by flow cytometry in neuroendocrine malignancies (vol 55, pg 535, 2002)
    Bryson, GJ
    Lear, D
    Williamson, R
    JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (10) : 800 - 800
  • [4] Interference of bone marrow CD56+ mesenchymal stromal cells in minimal residual disease investigation of neuroblastoma and other CD45-/CD56+ pediatric malignancies using flow cytometry
    Theodorakos, Ioannis
    Paterakis, Georgios
    Papadakis, Vassilios
    Vicha, Ales
    Topakas, Georgios
    Jencova, Pavia
    Karchilaki, Eirini
    Taparkou, Anna
    Tsagarakis, Nikolaos J.
    Polychronopoulou, Sophia
    PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
  • [5] Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TCRγδ+) and DERL-7 (CD56+/CD3−/TCRγδ−), derived from a single patient with CD56+ non-Hodgkin's lymphoma
    R Di Noto
    F Pane
    A Camera
    L Luciano
    M Barone
    C Lo Pardo
    P Boccuni
    M Intrieri
    B Izzo
    MR Villa
    M Macrí
    B Rotoli
    L Sacchetti
    F Salvatore
    L Del Vecchio
    Leukemia, 2001, 15 : 1641 - 1649
  • [6] Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TCRγδ+) and DERL-7 (CD56+/CD3-/TCRγδ-), derived from a single patient with CD56+ non-Hodgkin's lymphoma
    Di Noto, R
    Pane, F
    Camera, A
    Luciano, L
    Barone, M
    Lo Pardo, C
    Boccuni, P
    Intrieri, M
    Izzo, B
    Villa, MR
    Macrí, M
    Rotoli, B
    Sacchetti, L
    Salvatore, F
    Del Vecchio, L
    LEUKEMIA, 2001, 15 (10) : 1641 - 1649
  • [7] Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by Flow Cytometry Is Associated With NPM1 and FLT3 Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia
    Dalal, Bakul I.
    Mansoor, Soudeh
    Manna, Mita
    Pi, Steven
    Di Sauro, Giovanna
    Hogge, Donna E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (04): : 274 - 279
1